Kara Chew

A Phase 1/2a, Randomized Study of a Tfh-Targeting Genetic Vaccine Adjuvant Designed to Induce Broad, Durable Immune Responses

National Institute of Allergy and Infectious Diseases · U01

Contact PI · $4.3M · University of California Los Angeles

Ucla-Cdu Cfar

National Institute of Allergy and Infectious Diseases · P30

Project lead · $1M · University of California Los Angeles

A Phase 1/2A, Randomized Study of a T Follicular Helper (TFH)-Targeting Genetic Vaccine Strategy Designed to Induce Broad, Durable Immune Responses

Principal investigator · Recruiting · Phase 1, Phase 2

Kara Chew

A Single-arm Evaluation of the Effect of HCV Treatment on Cardiovascular Disease Risk

Principal investigator · Withdrawn · Phase 4

University of California, Los Angeles

A Prospective, Longitudinal Study of Endothelial Function in HIV/HCV Coinfected Subjects

Principal investigator · Completed

University of California, Los Angeles

Menopausal HT for Women Living With HIV (HoT)

Site PI · Recruiting · Phase 4

Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections